Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1245.50
-24.30
(-1.91%)
< Home
< Back
Dr. Reddys Laboratories Ltd. News
>>
Dr. Reddy’s partners DST, UoH to develop anti-psoriatic drugs
>>
Dr Reddy’s rises on receiving approval for Doxorubicin Hydrochloride Liposome Injection launch
>>
Dr Reddy’s receives approval for Doxorubicin Hydrochloride Liposome Injection launch
>>
Dr Reddy’s Labs surges on launching generic sofosbuvir & velpatasvir tablets
>>
Dr Reddy’s Labs launches generic sofosbuvir & velpatasvir tablets
>>
Dr. Reddy's Laboratories reports around three fold rise in Q4 consolidated net profit
>>
Dr. Reddy’s gets 11 USFDA observations for Bachupally facility
>>
Dr. Reddy’s gains on launching Ezetimibe & Simvastatin Tablets in US
>>
Dr. Reddy's Laboratories launches Ezetimibe & Simvastatin Tablets in the US Market
>>
Dr. Reddy’s gains on launching Progesterone Capsules is US markets
<<
<
88
89
90
...143
>
>>